title: Treating early choroidal neovascularisation with pegaptanib sodium in patients with neovascular age-related macular degeneration: findings of the PERSPECTIVES study.
authors.forename: Usha
authors.initials: U
authors.lastname: Chakravarthy
authors.forename: Giovanni
authors.initials: G
authors.lastname: Staurenghi
authors.forename: Kenneth
authors.initials: K
authors.lastname: Kwok
authors.forename: Charles S
authors.initials: CS
authors.lastname: Tressler
authors.forename: Ronald
authors.initials: R
authors.lastname: Buggage
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D052157:Aptamers, Nucleotide / Q000627:therapeutic use*; D020256:Choroidal Neovascularization / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D042241:Early Diagnosis; D006801:Humans; D008268:Macular Degeneration / Q000150:complications*; D008875:Middle Aged
chemical_list: D020533:Angiogenesis Inhibitors; D052157:Aptamers, Nucleotide; C495058:pegaptanib